US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. October 31, 2019

    Opioid MDL Attys Poised To Debate Next Bellwether Trials

    Attorneys in the opioid multidistrict litigation are gearing up for a closed-door debate next week over future bellwether trials, a showdown that will closely follow settlements that canceled the MDL's first trial.

  2. October 21, 2019

    $48B Opioid Deal Outcry May Presage Plaintiff Infighting

    A rapid outburst of opposition to a $48 billion "settlement framework" in opioid-crisis litigation unveiled Monday by four state attorneys general may signal a shift to local governments and states fighting not only with drug companies but also with each other.

  3. October 21, 2019

    State AGs Reach $48B Proposed Deal To End Opioid Cases

    Four attorneys general on Monday unveiled a proposed $48 billion deal with major drug companies — Teva Pharmaceuticals, Johnson & Johnson and the nation's largest drug distributors — to resolve a wave of opioid-crisis lawsuits.

  4. October 21, 2019

    Opioid Trial Halted By Drug Cos.' 11th Hour $260M Deal

    Two Ohio counties on Monday reached a deal worth $260 million with some of the nation's largest drug companies to avoid the first trial in opioid multidistrict litigation.

  5. October 17, 2019

    What To Watch As Opioid MDL Nears Moment Of Truth

    Amid whirlwind settlement talks, nationwide litigation over the pharmaceutical industry’s alleged role in the opioid crisis is on the cusp of a historic trial. Here, Law360 looks at settlement prospects and key issues if the epic courtroom showdown proceeds.

  6. October 16, 2019

    Drug Cos. Float Deals Worth $50B To End Opioid Cases

    Major drug manufacturers and distributors — including Johnson & Johnson and McKesson — are proposing deals that could be worth a combined $50 billion to resolve large portions of nationwide litigation over pharmaceutical industry liability for the opioid crisis, a source with direct knowledge of the offers told Law360 on Wednesday.

  7. October 10, 2019

    Ohio Trial In Opioid MDL Will Go Forward, 6th Circ. Says

    The Sixth Circuit on Thursday rejected eleventh-hour bids by the Ohio attorney general and drug companies to block an upcoming bellwether trial in multidistrict litigation accusing drugmakers of fueling the opioid crisis, rejecting the state's arguments that the counties in the case are usurping its authority.

  8. October 08, 2019

    Questions Swirl Around Opioid MDL Bellwether Trial

    A highly anticipated bellwether trial in the opioid multidistrict litigation is increasingly shrouded in uncertainty amid a flurry of settlements with drugmakers and aggressive maneuvers by drug distributors to avoid going before a jury.

  9. October 01, 2019

    J&J Inks $20.4M Deal Just Ahead Of Opioid Bellwether

    Johnson & Johnson has agreed to pay $20.4 million to resolve claims by two Ohio counties that were going to be at the center of the first bellwether trial later this month in multidistrict litigation against drugmakers blamed for the U.S. opioid crisis.

  10. October 01, 2019

    Opioid MDL Judge Rips Ohio AG's Late Bellwether Attack

    The Ohio attorney general's new campaign to torpedo the first bellwether trial in multidistrict opioid litigation is happening way too late and misconstrues key legal issues, the MDL's supervising judge told the Sixth Circuit on Tuesday.